BACKGROUND Clinical diagnosis of acute interstitial nephritis (AIN) is challenging because of lack of a diagnostic biomarker and requires a kidney biopsy. We hypothesized that AIN is mediated by specific T cell subsets such that specific T cell cytokine levels could serve as biomarkers to distinguish AIN from other causes of acute kidney disease (AKD).METHODS We enrolled consecutive sampling participants who underwent a kidney biopsy for AKD evaluation at 2 centers between 2015 and 2018. Three pathologists independently established AIN diagnosis through review of kidney biopsies. Through univariable and multivariable analysis of 12 selected urine and plasma cytokines, we identified 2 that were diagnostic of AIN.RESULTS Of the 218 participants, 32 (15%) were diagnosed with AIN by all 3 pathologists. Participants with AIN had consistently higher levels of urine TNF-α and IL-9 than those with other diagnoses, including acute tubular injury, glomerular diseases, and diabetic kidney disease, and those without any kidney disease. As compared with participants in the lowest quartile, we noted higher odds of AIN in participants in the highest quartiles of TNF-α levels (adjusted odds ratio, 10.9 [1.8, 65.9]) and IL-9 levels (7.5 [1.2, 45.7]) when controlling for blood eosinophils, leukocyturia, and proteinuria. Addition of biomarkers improved area under receiver operating characteristic curve over clinicians’ prebiopsy diagnosis (0.84 [0.78, 0.91]) vs. 0.62 [(0.53, 0.71]) and a model of current tests (0.84 [0.76, 0.91] vs. 0.69 [0.58, 0.80]).CONCLUSIONS Inclusion of urinary TNF-α and IL-9 improves discrimination over clinicians’ prebiopsy diagnosis and currently available tests for AIN diagnosis.FUNDING Supported by NIH awards K23DK117065, T32DK007276, K24DK090203, K23DK097201, R01DK113191, UG3-DK114866, P30DK079310; the Robert E. Leet and Clara Guthrie Patterson Trust; and American Heart Association award 18CDA34060118.
Dennis G. Moledina, F. Perry Wilson, Jordan S. Pober, Mark A. Perazella, Nikhil Singh, Randy L. Luciano, Wassim Obeid, Haiqun Lin, Michael Kuperman, Gilbert W. Moeckel, Michael Kashgarian, Lloyd G. Cantley, Chirag R. Parikh
Title and authors | Publication | Year |
---|---|---|
Adding Insult to Injury: The Spectrum of Tubulointerstitial Responses in Acute Kidney Injury
Megan L. Baker, Lloyd G. Cantley |
Journal of Clinical Investigation | 2025 |
Urine proteomics defines an immune checkpoint-associated nephritis signature
Long JP, Singh S, Dong Y, Yee C, Lin JS |
Journal for Immunotherapy of Cancer | 2025 |
Advances in the diagnosis of early biomarkers for acute kidney injury: a literature review
Yang H, Chen Y, He J, Li Y, Feng Y |
BMC Nephrology | 2025 |
Inflammatory markers mediate association of AIP with kidney failure risk: data from National Health and Nutrition Examination Survey (NHANES) 2005–2018
Guan C, Chen R, Wang Y |
Renal Failure | 2025 |
Acute Kidney Injury Associated with Novel Anticancer Therapies: Immunotherapy
Karam S, Ali A, Fung W, Mehta P, Nair S, Anandh U |
Kidney360 | 2025 |
Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: A Single-Center Experience of Biopsy-Proven Cases
Kommer A, Stortz M, Kraus D, Weinmann-Menke J |
Journal of Clinical Medicine | 2025 |
Update on Acute Tubulointerstitial Nephritis: Clinical Features, Immunologic Insights, and Diagnostic and Treatment Approaches
Sahutoglu T, Perazella MA |
Kidney International Reports | 2025 |
Urinary C-X-C-motif ligand 9 (CXCL9) in immune checkpoint inhibitor-associated acute interstitial nephritis.
Gupta S, Mistry K, Alikhan FM, Mejia SM, Sadarangani S, Cao A, Wells SL, Koval E, Liang C, Ortega JL, Zubiri L, Sun J, Lawless AR, Peterkin AC, Kernin IJ, Best R, Otten TJ, Yamada KS, Obeid W, Sullivan R, Kluger H, Buchbinder EI, Reynolds KL, Villani AC, Parikh CR, Moledina DG, Sise ME |
Kidney international | 2025 |
Toward Precision Medicine: Exploring the Landscape of Biomarkers in Acute Kidney Injury.
Nourie N, Ghaleb R, Lefaucheur C, Louis K |
Biomolecules | 2024 |
The diagnosis of acute interstitial nephritis caused by infection versus antibiotic-induced interstitial nephritis: a narrative review
Muhammad A, Zhang Y, Huang L, Yuan Q, Wang W, Pu J, Lin W, Tang R, Xiao X |
Clinical Kidney Journal | 2024 |
The development of lateral flow devices for urinary biomarkers to assess kidney health
D Souza S, Obeid W, Hernandez J, Hu D, Wen Y, Moledina DG, Albert A, Gregg A, Wheeler A, Philbrook HT, Parikh CR |
Scientific Reports | 2024 |
Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis.
Barsotti GC, Luciano R, Kumar A, Meliambro K, Kakade V, Tokita J, Naik A, Fu J, Peck E, Pell J, Reghuvaran A, Tanvir EM, Patel P, Zhang W, Li F, Moeckel G, Perincheri S, Cantley L, Moledina DG, Wilson FP, He JC, Menon MC |
Kidney International Reports | 2024 |
Biomarkers in pursuit of precision medicine for acute kidney injury: hard to get rid of customs
Lin KM, Su CC, Chen JY, Pan SY, Chuang MH, Lin CJ, Wu CJ, Pan HC, Wu VC |
Kidney Research and Clinical Practice | 2024 |
The Road to Precision Medicine for Acute Kidney Injury
Birkelo BC, Koyner JL, Ostermann M, Bhatraju PK |
Critical Care Medicine | 2024 |
Recommendations for clinical trial design in acute kidney injury from the 31st acute disease quality initiative consensus conference. A consensus statement.
Zarbock A, Forni LG, Koyner JL, Bell S, Reis T, Meersch M, Bagshaw SM, Fuhmann DY, Liu KD, Pannu N, Arikan AA, Angus DC, Duquette D, Goldstein SL, Hoste E, Joannidis M, Jongs N, Legrand M, Mehta RL, Murray PT, Nadim MK, Ostermann M, Prowle J, See EJ, Selby NM, Shaw AD, Srisawat N, Ronco C, Kellum JA |
Intensive Care Medicine | 2024 |
Urinary Biomarkers for Non-Invasive Diagnosis of Acute Interstitial Nephritis
Palanisamy T, Basu S, Srinivas BH, Shamanna S |
Indian Journal of Nephrology | 2024 |
Association of peripheral eosinophil count with chronic kidney disease progression risk: a retrospective cohort study in Chinese population
Ren Y, Zhang J, Hu X, Yu R, Tu Q, Li Y, Lin B, Zhu B, Shao L, Wang M |
Renal Failure | 2024 |
Baseline systemic inflammatory indices and clinicopathological features to predict the outcome of acute tubulointerstitial nephritis : A single-center retrospective study.
Dirim AB, Namazova N, Dirim MG, Oto OA, Artan AS, Hurdogan O, Ozluk Y, Yazici H |
Wiener klinische Wochenschrift | 2024 |
Biomarkers in acute kidney injury.
Ostermann M, Legrand M, Meersch M, Srisawat N, Zarbock A, Kellum JA |
Annals of intensive care | 2024 |
10 tips on how to use dynamic risk assessment and alerts for AKI
Quickfall D, La AM, Koyner JL |
Clinical Kidney Journal | 2024 |
Perioperative Acute Kidney Injury: Diagnosis, Prediction, Prevention, and Treatment
Douville NJ, Mathis M, Kheterpal S, Heung M, Schaub J, Naik A, Kretzler M |
Anesthesiology | 2024 |
Urinary RANTES and MCP-1 as noninvasive biomarkers for differential diagnosis and prediction of treatment response in acute interstitial nephritis
Baeg SI, Lee K, Jeon J, Lee JE, Kwon GY, Huh W, Jang HR |
Clinical Kidney Journal | 2024 |
Novel Biomarkers and Imaging Tests for Acute Kidney Injury Diagnosis in Patients with Cancer
Mistry K, Sadarangani S, Moreno D, Mejia SM, Moledina DG, Sise ME |
Kidney360 | 2024 |
External Validation of an Electronic Health Record–Based Diagnostic Model for Histological Acute Tubulointerstitial Nephritis
Moledina DG, Shelton K, Menez S, Aklilu AM, Yamamoto Y, Kadhim BA, Shaw M, Kent C, Makhijani A, Hu D, Simonov M, O\u2019Connor K, Bitzel J, Thiessen-Philbrook H, Wilson FP, Parikh CR |
Journal of the American Society of Nephrology : JASN | 2024 |
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis.
Sise ME, Wang Q, Seethapathy H, Moreno D, Harden D, Smith RN, Rosales IA, Colvin RB, Chute S, Cornell LD, Herrmann SM, Fadden R, Sullivan RJ, Yang NJ, Barmettler S, Wells S, Gupta S, Villani AC, Reynolds KL, Farmer J |
Journal for ImmunoTherapy of Cancer | 2023 |
Identification and validation of urine CXCL-9 as a biomarker for diagnosis of acute interstitial nephritis
Dennis Moledina, Wassim Obeid, Rex Smith, Ivy Rosales, Meghan Sise, Gilbert Moeckel, Michael Kashgarian, Michael Kuperman, Kirk Campbell, Sean Lefferts, Kristin Meliambro, Markus Bitzer, Mark Perazella, Randy Luciano, Jordan Pober, Lloyd Cantley, Robert Colvin, Francis Wilson, Chirag R. Parikh |
Journal of Clinical Investigation | 2023 |
Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine
Longhitano E, Muscolino P, Lo Re C, Ferrara SA, Cernaro V, Gembillo G, Tessitore D, Speranza D, Figura F, Santarpia M, Silvestris N, Santoro D, Franchina T |
Cancers | 2023 |
Urinary interleukins (IL)-6 and IL-10 in schoolchildren from an area with low prevalence of Schistosoma haematobium infections in coastal Kenya
Njaanake KH, Omondi J, Mwangi I, Jaoko WG, Anzala O |
2023 | |
Biomarkers in acute kidney injury: On the cusp of a new era?
Canney M, Clark EG, Hiremath S |
Journal of Clinical Investigation | 2023 |
Urinary TNF-α as a potential biomarker for chronic primary low back pain
Gevers-Montoro C, Puente-Tobares M, Monréal A, Conesa-Buendía FM, Piché M, Ortega-De Mues A |
Frontiers in integrative neuroscience | 2023 |
Genome-Wide Association Study in Acute Tubulointerstitial Nephritis
Zhou XJ, Su T, Xie J, Xie QH, Wang LZ, Hu Y, Chen G, Jia Y, Huang JW, Li G, Liu Y, Yu XJ, Nath SK, Tsoi LC, Patrick MT, Berthier CC, Liu G, Wang SX, Xu H, Chen N, Hao CM, Zhang H, Yang L |
Journal of the American Society of Nephrology : JASN | 2023 |
Immune checkpoint inhibitors and their interaction with proton pump inhibitors–related interstitial nephritis
Miao J, Herrmann SM |
Clinical Kidney Journal | 2023 |
APOBEC-1 deletion enhances cisplatin-induced acute kidney injury.
Guo X, Blanc V, Davidson NO, Velazquez H, Chen TM, Moledina DG, Moeckel GW, Safirstein RL, Desir GV |
Scientific Reports | 2023 |
The renal damage and mechanisms relevant to antitumoral drugs
Tang J, Yang N, Pan S, Ren P, Chen M, Jin J, He Q, Zeng Y |
Frontiers in Oncology | 2023 |
Do Novel Biomarkers Have Utility in the Diagnosis and Prognosis of AKI? CON
Coca SG |
2023 | |
Nephrotoxicity in the Age of Immune Checkpoint Inhibitors: Mechanisms, Diagnosis, and Management
Moturi K, Sharma H, Hashemi-Sadraei N |
International journal of molecular sciences | 2023 |
Immunological mechanisms underlying clinical phenotypes and noninvasive diagnosis of immune checkpoint inhibitor-induced kidney disease
Seethapathy H, Mistry K, Sise ME |
Immunological Reviews | 2023 |
Do Novel Biomarkers Have Utility in the Diagnosis and Prognosis of AKI?: Commentary.
Siew ED |
2023 | |
Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy.
Baker ML, Yamamoto Y, Perazella MA, Dizman N, Shirali AC, Hafez N, Weinstein J, Simonov M, Testani JM, Kluger HM, Cantley LG, Parikh CR, Wilson FP, Moledina DG |
Journal for ImmunoTherapy of Cancer | 2022 |
Urine testing to differentiate glomerular from tubulointerstitial diseases on kidney biopsy
Tran AC, Melchinger H, Weinstein J, Shaw M, Kent C, Perazella MA, Wilson FP, Parikh CR, Moledina DG |
Practical Laboratory Medicine | 2022 |
Kidney Biopsy in Patients with Cancer along the Last Decade: A Multicenter Study
Bolufer M, García-Carro C, Blasco M, Quintana LF, Shabaka A, Rabasco C, Draibe J, Merino A, Melero MR, Alonso F, Buxeda A, Batalha P, Visús MT, Soler MJ |
Journal of Clinical Medicine | 2022 |
Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment?
Bermejo S, Bolufer M, Riveiro-Barciela M, Soler MJ |
Frontiers in Medicine | 2022 |
Overview of Diagnostic Criteria and Epidemiology of Acute Kidney Injury and Acute Kidney Disease in the Critically Ill Patient
Birkelo BC, Pannu N, Siew ED |
Clinical journal of the American Society of Nephrology : CJASN | 2022 |
Immune-mediated tubule atrophy promotes acute kidney injury to chronic kidney disease transition
Xu L, Guo J, Moledina DG, Cantley LG |
Nature Communications | 2022 |
The role of kidney biopsy in immune checkpoint inhibitor nephrotoxicity
Moss EM, Perazella MA |
Frontiers in Medicine | 2022 |
Drug-Induced Acute Kidney Injury.
Perazella MA, Rosner MH |
Clinical journal of the American Society of Nephrology : CJASN | 2022 |
Urine Uromodulin as a Biomarker of Kidney Tubulointerstitial Fibrosis.
Melchinger H, Calderon-Gutierrez F, Obeid W, Xu L, Shaw MM, Luciano RL, Kuperman M, Moeckel GW, Kashgarian M, Wilson FP, Parikh CR, Moledina DG |
Clinical journal of the American Society of Nephrology : CJASN | 2022 |
Exploring Urinary Extracellular Vesicles and Immune Mediators as Biomarkers of Kidney Injury in COVID-19 Hospitalized Patients
Medeiros T, Alves LS, Cabral-Castro MJ, Silva AR, Xavier AR, Burger D, Almeida JR, Silva AA |
Diagnostics | 2022 |
Biomarkers for Early Diagnosis of AKI: Could It Backfire?
Claure-Del Granado R, Macedo E, Chávez-Íñiguez JS |
2022 | |
Serum Uromodulin Is a Possible Auxiliary Diagnostic Tool for Acute Tubular Injury and Acute Interstitial Nephritis: A Case Series
Usui R, Ogawa T, Iwasaki C, Nitta K, Koike M |
Case Reports in Nephrology and Dialysis | 2022 |
Development and external validation of a diagnostic model for biopsy-proven acute interstitial nephritis using electronic health record data.
Moledina DG, Eadon MT, Calderon F, Yamamoto Y, Shaw M, Perazella MA, Simonov M, Luciano R, Schwantes-An TH, Moeckel G, Kashgarian M, Kuperman M, Obeid W, Cantley LG, Parikh CR, Wilson FP |
Nephrology Dialysis Transplantation | 2022 |
A novel technology for home monitoring of lupus nephritis that tracks the pathogenic urine biomarker ALCAM
Lei R, Vu B, Kourentzi K, Soomro S, Danthanarayana AN, Brgoch J, Nadimpalli S, Petri M, Mohan C, Willson RC |
Frontiers in immunology | 2022 |
Cytokines and Immune Cell Phenotype in Acute Kidney Injury Associated With Immune Checkpoint Inhibitors
Farooqui N, Zaidi M, Vaughan L, McKee TD, Ahsan E, Pavelko KD, Villasboas JC, Markovic S, Taner T, Leung N, Dong H, Alexander MP, Herrmann SM |
Kidney International Reports | 2022 |
Definitions, phenotypes, and subphenotypes in acute kidney injury-Moving towards precision medicine.
Rodrigues CE, Endre ZH |
Nephrology (Carlton, Vic.) | 2022 |
Immune checkpoint inhibitor related nephrotoxicity: Advances in clinicopathologic features, noninvasive approaches, and therapeutic strategy and rechallenge
Miao J, Sise ME, Herrmann SM |
2022 | |
Infliximab for the treatment of patients with checkpoint inhibitor associated acute tubular interstitial nephritis
JS Lin, O Mamlouk, U Selamet, A Tchakarov, WF Glass, RA Sheth, RM Layman, R Dadu, N Abdel-Wahab, M Abdelrahim, A Diab, C Yee, A Abudayyeh |
OncoImmunology | 2021 |
Close Association Between Altered Urine-urothelium Barrier and Tertiary Lymphoid Structure Formation in the Renal Pelvis During Nephritis
O Ichii, M Hosotani, A Masum, T Horino, T Nakamura, T Namba, Y Otani, Y Elewa, Y Kon |
Journal of the American Society of Nephrology : JASN | 2021 |
Guidelines for Regulated Cell Death Assays: A Systematic Summary, A Categorical Comparison, A Prospective
, Z Li, R Lin, J Shan, Q Yu, R Wang, L Liao, W Yan, Z Wang, L Shang, Y Huang, Q Zhang, K Xiong |
Frontiers in Cell and Developmental Biology | 2021 |
Tubulointerstitial nephritis and uveitis syndrome following meningitis and systemic lymphadenopathy with persistent Toxoplasma immunoglobulin M: a case report
Y Oya, H Futami, T Nakazawa, K Ishijima, K Umemiya, F Takizawa, N Imai, H Kitamura, R Matsumura |
Journal of medical case reports | 2021 |
Exome Chip Analyses and Genetic Risk for IgA Nephropathy among Han Chinese
X Zhou, LC Tsoi, Y Hu, MT Patrick, K He, CC Berthier, Y Li, Y Wang, Y Qi, Y Zhang, T Gan, Y Li, P Hou, L Liu, S Shi, J Lv, H Xu, H Zhang |
Clinical journal of the American Society of Nephrology : CJASN | 2021 |
Prognostic Significance of Urinary Biomarkers in Patients Hospitalized With COVID-19
S Menez, DG Moledina, H Thiessen-Philbrook, FP Wilson, W Obeid, M Simonov, Y Yamamoto, CP Corona-Villalobos, C Chang, BT Garibaldi, W Clarke, S Farhadian, CD Cruz, SG Coca, CR Parikh |
American journal of kidney diseases : the official journal of the National Kidney Foundation | 2021 |
The Association of COVID-19 With Acute Kidney Injury Independent of Severity of Illness: A Multicenter Cohort Study
DG Moledina, M Simonov, Y Yamamoto, J Alausa, T Arora, A Biswas, LG Cantley, L Ghazi, JH Greenberg, M Hinchcliff, C Huang, SG Mansour, M Martin, A Peixoto, W Schulz, L Subair, JM Testani, U Ugwuowo, P Young, FP Wilson |
American journal of kidney diseases : the official journal of the National Kidney Foundation | 2021 |
Gene Expression Profiling in Kidney Transplants with Immune Checkpoint Inhibitor–Associated Adverse Events
B Adam, N Murakami, G Reid, K Du, R Jasim, C Boils, L Bu, P Hill, A Murray, K Renaudin, C Roufosse, A Weins, K Wen, L Riella, M Mengel |
Clinical journal of the American Society of Nephrology : CJASN | 2021 |
Ibrutinib-induced acute kidney injury via interstitial nephritis.
Markóth C, File I, Szász R, Bidiga L, Balla J, Mátyus J |
Renal Failure | 2021 |
The Challenges of Acute Interstitial Nephritis: Time to Standardize.
Moledina DG, Perazella MA |
2021 | |
Checkpoint inhibitor therapy-associated acute kidney injury: time to move on to evidence-based recommendations.
Perazella MA, Sprangers B |
Clinical Kidney Journal | 2021 |
The Promise of Tubule Biomarkers in Kidney Disease: A Review.
Ix JH, Shlipak MG |
American journal of kidney diseases : the official journal of the National Kidney Foundation | 2021 |
Urinary Cytokines Reflect Renal Inflammation in Acute Tubulointerstitial Nephritis: A Multiplex Bead-Based Assay Assessment.
Martinez Valenzuela L, Draibe J, Bestard O, Fulladosa X, Gómez-Preciado F, Antón P, Nadal E, Jové M, Cruzado JM, Torras J |
Journal of Clinical Medicine | 2021 |
Potential Value of TNF-α (-376 G/A) Polymorphism and Cystatin C (CysC) in the Diagnosis of Sepsis Associated Acute Kidney Injury (S-AK I) and Prediction of Mortality in Critically Ill patients.
Al-Amodi HS, Abdelsattar S, Kasemy ZA, Bedair HM, Elbarbary HS, Kamel HFM |
Frontiers in Molecular Biosciences | 2021 |
Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management.
Seethapathy H, Herrmann SM, Sise ME |
2021 | |
Urine interleukin-9 and tumor necrosis factor-α for prognosis of human acute interstitial nephritis.
Moledina DG, Wilson FP, Kukova L, Obeid W, Luciano R, Kuperman M, Moeckel GW, Kashgarian M, Perazella MA, Cantley LG, Parikh CR |
Nephrology Dialysis Transplantation | 2021 |
Urine Sediment Exam Provides More Diagnostic Information in AKI than Novel Urinary Biomarkers: PRO
Cavanaugh C |
2021 | |
Non-diabetic glycosuria as a diagnostic clue for acute tubulointerstitial nephritis in patients with azotemia
Lee T, Yang WS |
Renal Failure | 2020 |
Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: PRO.
Eijgelsheim M, Sprangers B |
2020 | |
Management of Drug-Associated Acute Interstitial Nephritis.
Barreto EF, Rule AD |
2020 | |
Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: Commentary.
Perazella MA |
2020 | |
AKI!Now Initiative: Recommendations for Awareness, Recognition, and Management of AKI.
Liu KD, Goldstein SL, Vijayan A, Parikh CR, Kashani K, Okusa MD, Agarwal A, Cerdá J |
Clinical journal of the American Society of Nephrology : CJASN | 2020 |
New Biomarkers in Acute Tubulointerstitial Nephritis: A Novel Approach to a Classic Condition.
Martinez Valenzuela L, Draibe J, Fulladosa X, Torras J |
International journal of molecular sciences | 2020 |
Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological Considerations.
Piscitani L, Sirolli V, Di Liberato L, Morroni M, Bonomini M |
International journal of molecular sciences | 2020 |
Eosinophilia and risk of incident end stage kidney disease
Tariq A, Okamato K, Tariq A, Rosenberg AZ, Soliman KM, Ploth DW, Atta MG, McMahon BA |
BMC Nephrology | 2020 |
Assessing the health of the nephron in acute kidney injury: biomarkers of kidney function and injury
S Menez, CR Parikh |
Current Opinion in Nephrology and Hypertension | 2019 |
Differentiating Acute Interstitial Nephritis from Acute Tubular Injury: A Challenge for Clinicians.
Moledina DG, Parikh CR |
Nephron | 2019 |
Positron emission tomography as an adjuvant diagnostic test in the evaluation of checkpoint inhibitor-associated acute interstitial nephritis.
Qualls D, Seethapathy H, Bates H, Tajmir S, Heidari P, Endres P, Reynolds K, Lawrence D, Sise M |
Journal for ImmunoTherapy of Cancer | 2019 |
Acute Kidney Injury with Immune Checkpoint Inhibitors: A Push beyond Case Reports
Carlos CA, Hsu RK |
Clinical journal of the American Society of Nephrology : CJASN | 2019 |